Abstract
Abstract
Purpose
To investigate the association between retinal vein occlusion (RVO) and evidence of previous, unnoticed inner nuclear layer (INL) infarction in the fellow eye.
Methods
This prospective case-control study compared the prevalence of INL lesions in the fellow eye of consecutive people with hypertension (PwHTN) with unilateral RVO versus a randomly chosen eye of an age-matched control group of PwHTN without RVO. En face slabs above the outer plexiform layer (OPL) were generated from 6 × 6 fovea-centered optical coherence tomography scans. Cross-sectional scans and en face slabs were surveyed for evidence of active/resolved ischemic INL lesions.
Results
69 PwHTN were included and assigned to two groups, i.e., the RVO group (n = 37; 22 BRVO and 15 CRVO) and the control group (n = 32). There was no inter-group difference regarding age, gender distribution, and background diseases. Resolved INL lesions were more frequent in the RVO group (n = 26) than in the control group (n = 4) (70.3% vs. 12.5%, p < 0.001). BRVO and CRVO cases had similar prevalence of INL lesions in their fellow eyes. Unlike diabetes, ischemic heart disease, and gender, INL lesions were associated with RVO (in the fellow eye) with an odds ratio of 15.7 (95%CI: 4.17–76.73, p < 0.001).
Conclusion
We identified a substantially higher prevalence of INL lesions in PwHTN with RVO compared to PwHTN without RVO. The atrophic appearance of lesions suggests they may serve as early markers of increased RVO risk in individuals with systemic or cardiovascular predisposing factors.
Funder
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Khayat M, Williams M, Lois N. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion. Surv Ophthalmol. 2018 Nov;63(6):816–50.
2. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, Midena E, Sivaprasad S, Tadayoni R, et al. Guidelines for the management of retinal vein occlusion by the european society of retina specialists (EURETINA). Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 2019;242(3):123–62.
3. Abtahi SH, Nourinia R, Mazloumi M, Nouri H, Arevalo JF, Ahmadieh H. Retinal ischemic cascade: new insights into the pathophysiology and imaging findings. Surv Ophthalmol. 2022 Dec 2;S0039-6257(22)00173-4.
4. Bakhoum MF, Freund KB, Dolz-Marco R, Leong BCS, Baumal CR, Duker JS, et al. Paracentral Acute Middle Maculopathy and the ischemic Cascade Associated with Retinal vascular occlusion. Am J Ophthalmol. 2018 Nov;195:143–53.
5. Burnasheva MA, Maltsev DS, Kulikov AN, Sherbakova KA, Barsukov AV. Association of Chronic Paracentral Acute Middle Maculopathy Lesions with Hypertension. Ophthalmol Retina. 2020 May;4(5):504–9.